Don't want ads? Subscribe or login now.

Abbott Asks For Reconsideration To End Stent FCA Suit

By Bryan Koenig · January 13, 2016, 3:38 PM EST

Abbott Laboratories asked a Texas federal judge Tuesday to rethink her decision forcing the company to face a whistleblower's False Claims Act lawsuit alleging it marketed stents for off-label uses, arguing...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Reconsideration

Case Information

Case Title

USA v. Abbott Laboratories et al

Case Number

3:06-cv-01769

Court

Texas Northern

Nature of Suit

Other Statutes: Other Statutory Actions

Date Filed

September 26, 2006

Recent Articles By Bryan

July 17, 2024
FTC Cites 3rd Circ. In Defending Noncompete Ban
July 17, 2024
Heart Doctor's Sham Suit Claims Cut From Antitrust Row
July 16, 2024
FTC's In-House Kroger Case Delayed Until After Fed Suit
July 10, 2024
FTC Must Think Hard Before Trying More Rules, Commish Says
June 18, 2024
Meat Plant Workers Seek OK On Latest $4M Wage-Fix Deal
June 04, 2024
DOJ Remains 'Clear Eyed' About No-Poach Prosecutions
May 30, 2024
Divided FTC Won't Delay Kroger-Albertsons In-House Case
May 28, 2024
Kroger, Albertsons Must Give FTC Texts, Written Notes
May 10, 2024
Chamber OK'd To Intervene Against FTC Noncompete Rule
May 06, 2024
Judge Weighs Discovery Need On McD's No-Poach Standard